Abstract
Hematopoietic stem cells (HSC) have provided a model for the isolation, enrichment and transplantation of stem cells. Gene targeting studies in mice have shown that expression of the thrombopoietin receptor (TpoR) is linked to the accumulation of HSCs capable to generate long‐term blood repopulation when injected into irradiated mice. The powerful increase in vivo in HSC numbers by retrovirally transduced HOX4B, a homeotic gene, along with the role of the TpoR, suggested that stem cell fate, renewal, differentiation and number can be controlled. The discovery of the precise region of the mouse embryo where HSCs originate and the isolation of supporting stromal cell lines open the possibility of identifying the precise signals required for HSC choice of fate. The completion of human genome sequencing coupled with advances in gene expression profiling using DNA microarrays will enable the identification of key genes deciding the fate of stem cells. Downstream from HSCs, multipotent hematopoietic progenitor cells appear to co‐express a multiplicity of genes characteristic of different blood lineages. Genomic approaches will permit the identification of the select group of genes consolidated by the commitment of these multipotent progenitors towards one or the other of the blood lineages. Studies with neural stem cells pointed to the unexpected plastic nature of these cells. Isolation of stem cells from multiple tissues may suggest that, providing the appropriate environment/signal, tissues could be regenerated in the laboratory and used for transplantation. A spectacular example of influence of the environment on cell fate was revealed decades ago by using mouse embryonic stem cells (ES). Injected into blastocysts, ES cells contribute to the formation of all adult tissues. Injected into adult mice, ES cells become cancer cells. After multiple passages as ascites, when injected back into the blastocyst environment, ES‐ derived cancer cells behaved again as ES cells. More recently, the successful cloning of mammals and reprogramming of transferred nuclei by factors in the cytoplasm of oocytes turned back the clock by showing that differentiated nuclei can be “re‐booted” to generate again the stem cells for different tissues.
References
- 1. Lemischka I.R., Clonal in vivo behavior of the totipotent hematopoietic stem cell, Semin Immunol., 3: 349–55, 1991. [PubMed] [Google Scholar]
- 2. Spangrude G.J., Smith L., Uchida N., Ikuta K., Heimfeld S., Friedman J., Weissman I.L., Mouse hematopoietic stem cells, Blood, 78: 1395–402, 1991. [PubMed] [Google Scholar]
- 3. Medvinsky A., Dzierzak E., Development of the hematopoietic stem cell: can we describe it?, Blood, 94: 3613–4, 1999. [PubMed] [Google Scholar]
- 4. Medvinsky A., Dzierzak E., Definitive hematopoiesis is autonomously initiated by the AGM region, Cell, 86: 897–906, 1996. [DOI] [PubMed] [Google Scholar]
- 5. Wu H., Liu X., Jaenisch R., Lodish H.F., Generation of committed erythroid BFU‐E and CFU‐E progenitors does not require erythropoietin or the erythropoietin receptor, Cell, 83: 59–67, 1995. [DOI] [PubMed] [Google Scholar]
- 6. Yoder M.C., Hiatt K., Dutt P, Mukherjee P., Bodine D. M., Orlic D., Characterization of definitive lymphohematopoietic stem cells in the day 9 murine yolk sac, Immunity, 7: 335–44, 1997. [DOI] [PubMed] [Google Scholar]
- 7. Harrison D.E., Zhong R.K., Jordan C.T., Lemischka I.R., Astle C.M., Relative to adult marrow, fetal liver repopulates nearly five times more effectively long‐term than short‐term, Exp Hematol., 25: 293–7, 1997. [PubMed] [Google Scholar]
- 8. Morrison S.J., Hemmati H.D., Wandycz A.M., Weissman I.L., The purification and characterization of fetal liver hematopoietic stem cells, Proc Natl Acad Sci USA., 92: 10302–6, 1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Constantinescu S. N., Wu H., Liu X., Beyer W., Fallon A., Lodish H.F., The anemic Friend virus gp55 envelope protein induces erythroid differentiation in fetal liver colony‐forming units‐erythroid, Blood, 91: 1163–72, 1998. [PubMed] [Google Scholar]
- 10. de Bruijn M.F., Speck N.A., Peeters M.C., Dzierzak E., Definitive hematopoietic stem cells first develop within the major arterial regions of the mouse embryo, Embo J., 19: 2465–74, 2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. North T., Gu T.L., Stacy T., Wang Q., Howard L., Binder M., Marin‐Padilla M., Speck N.A., Cbfa2 is required for the formation of intra‐aortic hematopoietic clusters, Development, 126: 2563–75, 1999. [DOI] [PubMed] [Google Scholar]
- 12. Lemischka I.R., Microenvironmental regulation of hematopoietic stem cells, Stem Cells, 15: 63–8, 1997. [DOI] [PubMed] [Google Scholar]
- 13. Watowich S.S., Wu H., Socolovsky M., Klingmuller U., Constantinescu S.N., Lodish H.F., Cytokine receptor signal transduction and the control of hematopoietic cell development, Ann Rev Cell Dev Biol, 12: 91–128, 1996. [DOI] [PubMed] [Google Scholar]
- 14. D'Andrea A. D., Lodish H.F., Wong G.G., Expression cloning of the murine erythropoietin receptor, Cell, 57: 277–85, 1989. [DOI] [PubMed] [Google Scholar]
- 15. Socolovsky M., Constantinescu S.N., Bergelson S., Sirotkin A., Lodish H.F., Cytokines in hematopoiesis: specificity and redundancy in receptor function, Adv Protein Chem., 52: 141–98, 1998. [DOI] [PubMed] [Google Scholar]
- 16. Constantinescu S.N., Ghaffari S., Lodish H.F., The Erythropoietin Receptor: Structure, Activation and Intracellular Signal Transduction, Trends in Endocrinology and Metabolism, 10: 18–23, 1999. [DOI] [PubMed] [Google Scholar]
- 17. Yoshimura A., Longmore G., Lodish H.F., Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone‐independent activation and tumorigenicity, Nature, 348: 647–9, 1990. [DOI] [PubMed] [Google Scholar]
- 18. Longmore G.D., Pharr P.N., Lodish H.F., A constitutively activated erythropoietin receptor stimulates proliferation and contributes to transformation of multipotent, committed nonerythroid and erythroid progenitor cells, Mol. Cell. Biol, 14: 2266–2277, 1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Kaushansky K., Thrombopoietin and hematopoietic stem cell development, Ann N Y Acad Sci., 872: 314–9, 1999. [DOI] [PubMed] [Google Scholar]
- 20. Kaushansky K., Lok S., Holly R.D., Broudy V.C., Lin N., Bailey M.C., Forstrom J.W., Buddle M.M., Oort P.J., Hagen F.S., Promotion of megakaryocyte progenitor expansion and differentiation by the c‐Mpl ligand thrombopoietin, Nature, 369: 568–71, 1994. [DOI] [PubMed] [Google Scholar]
- 21. Kaushansky K., Broudy V. C., Grossmann A., Humes J., Lin N., Ren H.P., Bailey M.C., Papayannopoulou T., Forstrom J.W., Sprugel K.H., Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy, J. Clin. Invest., 96: 1683–7, 1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Kirby S., Walton W., Smithies O., Hematopoietic stem cells with controllable tEpoR transgenes have a competitive advantage in bone marrow transplantation, Blood, 95: 3710–5, 2000. [PubMed] [Google Scholar]
- 23. Zandstra P.W., Lauffenburger D.A., Eaves C.J., A ligand‐receptor signaling threshold model of stem cell differentiation control: a biologically conserved mechanism applicable to hematopoiesis, Blood, 96: 1215–22, 2000. [PubMed] [Google Scholar]
- 24. Eaves C., Miller C., Conneally E., Audet J., Oostendorp R., Cashman J., Zandstra P, Rose‐John S., Piret J., Eaves A., Introduction to stem cell biology in vitro. Threshold to the future, Ann. N.Y. Acad. Sci., 872: 1–8, 1999. [DOI] [PubMed] [Google Scholar]
- 25. Eckner R.J., Hettrick K.L., Greenberger J.S., Bennett M., Extended self‐renewal capacity of pluripotent hemopoietic stem cells: association with persistent Friend spleen focus‐forming virus, Cell, 31: 731–8, 1982. [DOI] [PubMed] [Google Scholar]
- 26. Sauvageau G., Thorsteinsdottir U., Eaves C.J., Lawrence H.J., Largman C., Lansdorp P.M., Humphries R.K., Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo , Genes Dev., 9: 1753–65, 1995. [DOI] [PubMed] [Google Scholar]
- 27. Ruscetti S.K., Erythroleukaemia induction by the Friend spleen focus‐forming virus, Baillieres Clin. Haematol., 8: 225–47, 1995. [DOI] [PubMed] [Google Scholar]
- 28. Constantinescu S.N., Liu X., Beyer W., Fallon A., Shekar S., Henis Y.I., Smith S.O., Lodish H.F., Activation of the erythropoietin receptor by the gp55‐P viral envelope protein is determined by a single amino acid in its transmembrane domain, Embo. J., 18: 3334–47, 1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Zandstra P.W., Conneally E., Petzer A.L., Piret J.M., Eaves C.J., Cytokine manipulation of primitive human hematopoietic cell self‐ renewal, Proc. Natl. Acad. Sci. USA, 94: 4698–703, 1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Peled A., Petit I., Kollet O., Magid M., Ponomaryov T., Byk T., Nagler A., Ben‐Hur H., Many A., Shultz L., Lider O., Alon R., Zipori D., Lapidot T., Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4, Science, 283: 845–8, 1999. [DOI] [PubMed] [Google Scholar]
- 31. Papayannopoulou T., Nakamoto B., Peripheralization of hemopoietic progenitors in primates treated with anti‐VLA4 integrin, Proc. Natl. Acad. Sci. USA, 90: 9374–8, 1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Enver T., Heyworth C.M., Dexter T.M., Do stem cells play dice Blood, 92: 348–51, 1998. [PubMed] [Google Scholar]
- 33. Socolovsky M., Lodish H.F., Daley G.Q., Control of hematopoietic differentiation: lack of specificity in signaling by cytokine receptors, Proc. Natl. Acad. Sci. USA, 95: 6573–5, 1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Shivdasani R.A., Orkin S.H., The transcriptional control of hematopoiesis, Blood, 87: 4025–39, 1996. [PubMed] [Google Scholar]
- 35. Fukunaga R., Ishizaka‐Ikeda E., Nagata S., Growth and differentiation signals mediated by different regions in the cytoplasmic domain of granulocyte colony‐stimulating factor receptor, Cell, 74: 1079–87, 1993. [DOI] [PubMed] [Google Scholar]
- 36. Borzillo G.V., Ashmun R.A., Sherr C.J., Macrophage lineage switching of murine early pre‐B lymphoid cells expressing transduced fms genes, Mol. Cell. Biol., 10: 2703–14, 1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Hu M., Krause D., Greaves M., Sharkis S., Dexter M., Heyworth C., Enver T., Multilineage gene expression precedes commitment in the hemopoietic system, Genes Dev., 11: 774–85, 1997. [DOI] [PubMed] [Google Scholar]
- 38. Enver T., B‐cell commitment: Pax5 is the deciding factor, Curr. Biol., 9: R933–5, 1999. [DOI] [PubMed] [Google Scholar]
- 39. Wineman J., Moore K., Lemischka I., Muller‐Sieburg C., Functional heterogeneity of the hematopoietic microenvironment: rare stromal elements maintain long‐term repopulating stem cells, Blood, 87: 4082–90, 1996. [PubMed] [Google Scholar]
- 40. Moore K.A., Ema H., Lemischka I.R., in vitro maintenance of highly purified, transplantable hematopoietic stem cells, Blood, 89: 4337–47, 1997. [PubMed] [Google Scholar]
- 41. Moore K.A., Pytowski, B. , Witte L., Hicklin D., Lemischka I.R., Hematopoietic activity of a stromal cell transmembrane protein containing epidermal growth factor‐like repeat motifs, Proc. Natl. Acad. Sci. USA, 94: 4011–6, 1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Phillips R.L., Ernst R.E., Brunk B., Ivanova N., Mahan M.A., Deanehan J.K., Moore K.A., Overton G. C., Lemischka I.R., The genetic program of hematopoietic stem cells, Science, 288: 1635–40, 2000. [DOI] [PubMed] [Google Scholar]
- 43. Wiesmann A., Phillips R.L., Mojica M., Pierce L.J., Searles A.E., Spangrude G.J., Lemischka I., Expression of CD27 on murine hematopoietic stem and progenitor cells, Immunity, 12: 193–9, 2000. [DOI] [PubMed] [Google Scholar]
- 44. Mackarehtschian K., Hardin J.D., Moore K.A., Boast S., Goff S.P., Lemischka I.R., Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors, Immunity, 3: 147–61, 1995. [DOI] [PubMed] [Google Scholar]
- 45. Petrenko O., Beavis A., Klaine M., Kittappa R., Godin I., Lemischka I.R., The molecular characterization of the fetal stem cell marker AA4, Immunity, 10: 691–700, 1999. [DOI] [PubMed] [Google Scholar]
- 46. Punzel M., Wissink S.D., Miller J.S., Moore K.A., Lemischka I.R., Verfaillie C.M., The myeloid‐lymphoid initiating cell (ML‐IC) assay assesses the fate of multipotent human progenitors in vitro , Blood, 93: 3750–6, 1999. [PubMed] [Google Scholar]
- 47. Punzel M., Moore K.A., Lemischka I.R., Verfaillie C.M., The type of stromal feeder used in limiting dilution assays influences frequency and maintenance assessment of human long‐term culture initiating cells, Leukemia, 13: 92–7, 1999. [DOI] [PubMed] [Google Scholar]
- 48. Reynolds B.A., Weiss S., Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system, Science, 255: 1707–10, 1992. [DOI] [PubMed] [Google Scholar]
- 49. Johansson C.B., Momma S., Clarke D.L., Risling M., Lendahl U., Frisen J., Identification of a neural stem cell in the adult mammalian central nervous system, Cell, 96: 25–34, 1999. [DOI] [PubMed] [Google Scholar]
- 50. Doetsch F., Caille I., Lim D.A., Garcia‐Verdugo J.M., Alvarez‐Buylla A., Subventricular zone astrocytes are neural stem cells in the adult mammalian brain, Cell, 97: 703–16, 1999. [DOI] [PubMed] [Google Scholar]
- 51. Barres B.A., Barde Y., Neuronal and glial cell biology, Curr. Opin. Neurobiol., 10: 642–8, 2000. [DOI] [PubMed] [Google Scholar]
- 52. Chernoff E.A., Spinal cord regeneration: a phenomenon unique to urodeles Int. J. Dev. Biol., 40: 823–31, 1996. [PubMed] [Google Scholar]
- 53. Morrison S.J., White P.M., Zock C., Anderson D.J., Prospective identification, isolation by flow cytometry, and in vivo self‐renewal of multipotent mammalian neural crest stem cells, Cell, 96: 737–49, 1999. [DOI] [PubMed] [Google Scholar]
- 54. Gritti A., Frolichsthal‐Schoeller P., Galli R., Parati E.A., Cova L., Pagano S.F., Bjornson C.R., Vescovi A.L., Epidermal and fibroblast growth factors behave as mitogenic regulators for a single multipotent stem cell‐like population from the subventricular region of the adult mouse forebrain, J. Neurosci., 19: 3287–97, 1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Bjornson C.R., Rietze R.L., Reynolds B.A., Magli M.C., Vescovi A.L., Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo , Science, 283: 534–7, 1999. [DOI] [PubMed] [Google Scholar]
- 56. Gussoni E., Soneoka Y., Strickland C.D., Buzney E.A., Khan M.K., Flint A.F., Kunkel L.M., Mulligan R.C., Dystrophin expression in the mdx mouse restored by stem cell transplantation, Nature, 401: 390–4, 1999. [DOI] [PubMed] [Google Scholar]
- 57. Jackson K.A., Mi T., Goodell M.A., Hematopoietic potential of stem cells isolated from murine skeletal muscle, Proc. Natl. Acad. Sci. USA, 96: 14482–6, 1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Kopen G.C., Prockop D.J., Phinney D.G., Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains, Proc. Natl. Acad. Sci. USA, 96: 10711–6, 1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Galli R., Borello U., Gritti A., Minasi M.G., Bjornson C., Coletta M., Mora M., De Angelis M.G., Fiocco R., Cossu G., Vescovi A.L., Skeletal myogenic potential of human and mouse neural stem cells, Nat. Neurosci., 3: 986–91, 2000. [DOI] [PubMed] [Google Scholar]
- 60. Clarke D.L., Johansson C.B., Wilbertz J., Veress B., Nilsson E., Karlstrom H., Lendahl U., Frisen J., Generalized potential of adult neural stem cells, Science, 288: 1660–3, 2000. [DOI] [PubMed] [Google Scholar]
- 61. Keller G., Wall C., Fong A.Z., Hawley T.S., Hawley R.G., Overexpression of HOX11 leads to the immortalization of embryonic precursors with both primitive and definitive hematopoietic potential, Blood, 92: 877–87, 1998. [PubMed] [Google Scholar]
- 62. Weiss M.J., Keller G., Orkin S.H., Novel insights into erythroid development revealed through in vitro differentiation of GATA‐1 embryonic stem cells., Genes Dev., 8: 1184–97, 1994. [DOI] [PubMed] [Google Scholar]
- 63. Illmensee K., Mintz B., Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts, Proc. Natl. Acad. Sci. USA, 73: 549–53, 1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Thomson J.A., Itskovitz‐Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J. M., Embryonic stem cell lines derived from human blastocysts, Science, 282: 1145–7, 1998. [DOI] [PubMed] [Google Scholar]
- 65. Shamblott M.J., Axelman J., Wang S., Bugg E.M., Littlefield J.W., Donovan P.J., Blumenthal P.D., Huggins G.R., Gearhart J.D., Derivation of pluripotent stem cells from cultured human primordial germ cells, Proc. Natl. Acad. Sci. USA, 95: 13726–31, 1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. Solter D., Gearhart J., Putting stem cells to work, Science, 283: 1468–70, 1999. [DOI] [PubMed] [Google Scholar]
- 67. Wakayama T., Rodriguez I., Perry A.C., Yanagimachi R., Mombaerts P., Mice cloned from embryonic stem cells., Proc. Natl. Acad. Sci. USA, 96: 14984–9, 1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Rideout W.M. 3rd, Wakayama T., Wutz A., Eggan K., Jackson‐Grusby L., Dausman J., Yanagimachi R., Jaenisch R., Generation of mice from wild‐type and targeted ES cells by nuclear cloning, Nat. Genet., 24: 109–10, 2000. [DOI] [PubMed] [Google Scholar]
- 69. Gurdon J.B., Laskey R.A., Reeves O.R., The developmental capacity of nuclei transplanted from keratinized skin cells of adult frogs, J. Embryol. Exp. Morphol., 34: 93–112, 1975. [PubMed] [Google Scholar]
- 70. Wilmut I., Schnieke A.E., McWhir J., Kind A.J., Campbell K.H., Viable offspring derived from fetal and adult mammalian cells, Nature, 385: 810–3, 1997. [DOI] [PubMed] [Google Scholar]
- 71. Schnieke A.E., Kind A.J., Ritchie W.A., Mycock K., Scott A.R., Ritchie M., Wilmut I., Colman A., Campbell K.H., Human factor IX transgenic sheep produced by transfer of nuclei from transfected fetal fibroblasts, Science, 278: 2130–3, 1997. [DOI] [PubMed] [Google Scholar]
- 72. Wakayama T., Perry A.C., Zuccotti M., Johnson K.R., Yanagimachi R., Full‐term development of mice from enucleated oocytes injected with cumulus cell nuclei, Nature, 394: 369–74, 1998. [DOI] [PubMed] [Google Scholar]
- 73. Wakayama T., Yanagimachi R., Fertilisability and developmental ability of mouse oocytes with reduced amounts of cytoplasm, Zygote, 6: 341–6, 1998. [DOI] [PubMed] [Google Scholar]
- 74. Baguisi A., Behboodi E., Melican D.T., Pollock J.S., Destrempes M.M., Cammuso C., Williams J.L., Nims S.D., Porter C.A., Midura P., Palacios M.J., Ayres S.L., Denniston R.S., Hayes M.L., Ziomek C.A., Meade H.M., Godke R.A., Gavin W.G., Overstrom E.W., Echelard Y., Production of goats by somatic cell nuclear transfer, Nat. Biotechnol., 17: 456–61, 1999. [DOI] [PubMed] [Google Scholar]
- 75. Morrison S.J., Stem cell potential: Can anything make anything Current Biology, 11: R7–R9, 2001. [DOI] [PubMed] [Google Scholar]
- 76. Kondo T., Raff M., Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells, Science, 289: 1754–7, 2000. [DOI] [PubMed] [Google Scholar]
- 77. Lagasse E., Connors H., Al‐Dhalimy M., Reitsma M., Dohse M., Osborne L., Wang X., Finegold M., Weissman I.L., Grompe M., Purified hematopoietic stem cells can differentiate into hepatocytes in vivo , Nat. Med., 6: 1229–34, 2000. [DOI] [PubMed] [Google Scholar]